...
首页> 外文期刊>Inorganic Chemistry: A Research Journal that Includes Bioinorganic, Catalytic, Organometallic, Solid-State, and Synthetic Chemistry and Reaction Dynamics >FIVE-COORDINATE PLATINUM OLEFIN COMPLEXES - SYNTHESIS, H-1 NMR INVESTIGATIONS, AND CRYSTAL STRUCTURE OF A PLATINUM ETA(2)-ETHYLENE CROWN ETHER COMPLEX
【24h】

FIVE-COORDINATE PLATINUM OLEFIN COMPLEXES - SYNTHESIS, H-1 NMR INVESTIGATIONS, AND CRYSTAL STRUCTURE OF A PLATINUM ETA(2)-ETHYLENE CROWN ETHER COMPLEX

机译:五配位铂烯烃复合物-铂ETA(2)-乙烯-冠醚配合物的合成,H-1 NMR研究和晶体结构

获取原文
获取原文并翻译 | 示例

摘要

The synthesis of derivatives of the tumor-inhibiting metal complex cisplatin (INN), cis-diamminedichloroplatinum(II), is presently aimed at achieving an improved water-solubility, a slower decomposition rate of the substance to toxic byproducts through shielding of the platinum using bulky groups as done in carboplatin,(1) and an improved membrane permeability through an increased lipophilia of the ligands. High lipophilic and kinetically inert Pt(IV) compounds are good candidates for oral application.(2) We used crown ethers, which, owing to their structure and their good solubility properties both in lipophilic and in hydrophilic media, meet the above mentioned requirements and are therefore suitable constituents for new complexes. Several platinum crown ether complexes are known in the Literature,(3,4) but in these adducts the platinum fragment is only Linked through hydrogen bonds to the macrocycle. We previously reported on a four-coordinate crown ether complex in which the platinum is involved in covalent bonding to the crown,(5) which shows reasonable antitumor activity. Here we describe the synthesis, magnetic properties, and X-ray structure analysis of the first example of a five-coordinate platinum crown ether complex with ethylene as the fifth ligand. The structural properties of this compound are in good agreement with those generally made for the rising number of five-coordinate platinum complexes with olefins and other sterically hindered ligands.(6) [References: 23]
机译:抑制肿瘤的金属配合物顺铂(INN)的衍生物,即顺二氨二氯铂(II)的合成目前旨在获得改善的水溶性,即通过使用铂保护铂来降低该物质分解为有毒副产物的速率。如卡铂(1)中所述的大基团,以及通过增加配体的亲脂性而提高的膜通透性。高亲脂性和动力学惰性的Pt(IV)化合物是口服应用的良好候选者。(2)我们使用冠醚,由于冠醚的结构及其在亲脂性和亲水性介质中的良好溶解性,可以满足上述要求,并且因此是新复合物的合适成分。几种铂冠醚络合物在文献中是已知的(3,4),但在这些加合物中,铂片段仅通过氢键连接至大环。我们先前曾报道过一种四配位冠醚配合物,其中铂与冠共价键合(5),显示出合理的抗肿瘤活性。在这里,我们描述了以乙烯为第五种配体的五配位铂冠醚配合物的第一个实例的合成,磁性和X射线结构分析。该化合物的结构性质与那些与烯烃和其他空间受阻配体的五配位铂络合物的数量不断增加的一般结构具有良好的一致性。(6)[参考文献:23]

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号